{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:48:42Z","timestamp":1790700522284,"version":"4.1.0"},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,12,17]],"date-time":"2010-12-17T00:00:00Z","timestamp":1292544000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Muscle and Nerve"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recently, we reported that mutations in the neuropathy target esterase (NTE) gene cause autosomal recessive motor neuron disease (NTE\u2010MND). We describe clinical, neurophysiologic, and neuroimaging features of affected subjects in the index families. NTE\u2010MND subjects exhibited progressive lower extremity spastic weakness that began in childhood and was later associated with atrophy of distal leg and intrinsic hand muscles. NTE\u2010MND resembles Troyer syndrome, except that short stature, cognitive impairment, and dysmorphic features, which often accompany Troyer syndrome, are not features of NTE\u2010MND. Early onset, symmetry, and slow progression distinguish NTE\u2010MND from typical amyotrophic lateral sclerosis. NTE is implicated in organophosphorus compound\u2013induced delayed neurotoxicity (OPIDN). NTE\u2010MND patients have upper and lower motor neuron deficits that are similar to OPIDN. Motor neuron degeneration in subjects with NTE mutations supports the role of NTE and its biochemical cascade in the molecular pathogenesis of OPIDN and possibly other degenerative neurologic disorders. Muscle Nerve, 2011<\/jats:p>","DOI":"10.1002\/mus.21777","type":"journal-article","created":{"date-parts":[[2010,12,20]],"date-time":"2010-12-20T05:30:54Z","timestamp":1292823054000},"page":"19-25","source":"Crossref","is-referenced-by-count":31,"title":["Motor neuron disease due to neuropathy target esterase gene mutation: Clinical features of the index families"],"prefix":"10.1002","volume":"43","author":[{"given":"Shirley","family":"Rainier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Albers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Dyck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. Petter","family":"Eldevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Wilcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy J.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John K.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,12,17]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2007.12.018"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-005-1415-3"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-996-0011-1"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000078189.73611.DF"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.5.706"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1967.00470230025003"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng937"},{"key":"e_1_2_6_9_2","first-page":"1105","article-title":"Troyer syndrome revisited. A clinical and radiological study of a complicated hereditary spastic paraplegia","volume":"251","author":"Proukakis C","year":"2004","journal-title":"J Neurol"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1131"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/bj3440625","article-title":"Neuropathy target esterase","volume":"344","author":"Glynn P","year":"1999","journal-title":"Biochem J"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1974.tb04404.x"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(99)00043-X"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.21.040181.002455"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-374367-1.00067-7"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(59)91486-2"},{"key":"e_1_2_6_17_2","volume-title":"Anticholinesterase agents. Goodman and Gilman's pharmacologic basis of therapeutics","author":"Taylor P","year":"1996"},{"key":"e_1_2_6_18_2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.5694\/j.1326-5377.1969.tb92252.x","article-title":"Orthocresyl phosphate neuropathy: report of an outbreak in Fiji","volume":"10","author":"Sorokin M","year":"1969","journal-title":"Med J Austral"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0278-6915(90)90047-Q"},{"key":"e_1_2_6_20_2","first-page":"359","article-title":"Outbreaks of paralytic disease in West Bengal due to tricresyl phosphate poisoning","volume":"63","author":"Sarkar JK","year":"1974","journal-title":"J Indian Med Assoc"},{"key":"e_1_2_6_21_2","first-page":"133","article-title":"Toxic neuropathy in Raipur due to triorthocresylphosphate (TOCP)","volume":"23","author":"Mehta RS","year":"1975","journal-title":"J Assoc Physicians India"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1978.00500320050011"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2010.03.1120"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3015-08.2008"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920110790909740"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2009.11.004"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2008.07.004"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.010264"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-010-0646-5"}],"container-title":["Muscle &amp; Nerve"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.21777","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmus.21777","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mus.21777","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T19:47:15Z","timestamp":1696880835000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mus.21777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,17]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1002\/mus.21777"],"URL":"https:\/\/doi.org\/10.1002\/mus.21777","archive":["Portico"],"relation":{},"ISSN":["0148-639X","1097-4598"],"issn-type":[{"value":"0148-639X","type":"print"},{"value":"1097-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,17]]}}}